The 21st century is an exciting time in the field of medical research. At the crossroads of increased understanding of the human genome, the genetic makeup of cell invasions and aberrations (like cancer), and the improved understanding of human longevity, comes Pulse Biosciences.

Focusing on bioelectric medicine, Pulse’s proprietary Nano-Pulse Stimulation (NPS) technology has the potential to treat a range of cosmetic and medical conditions for which we currently have no known optimized solutions. One example: the quick, painless removal of skin lesions (like melanomas), which would also have cosmetic uses, utilizing NPS.

Innovation that enhances wellness, which, in turn, potentially generates wealth–that’s a Bob Duggan specialty.

Everyone has genius inside of them; it’s just a matter of recognizing and cultivating those traits which enable the genius to flourish.

At least, that’s the premise of Bob Duggan’s passion project, Genius Inc. Even the word “genius” comes from a Latin word meaning “attendant spirit from one’s birth,” which gave rise to the later senses of the word: “a person’s characteristic disposition” (16th century), then a person’s natural ability, and ultimately “exceptional natural ability,” the sense that’s been around since about the 17th century. Perhaps, though, we can trace that word’s meaning backward again within ourselves, to a spirit inherent in all of our abilities?

Genius Inc works with organizations and individuals (everyone from top executives to children) to generate “genius culture” within a group or the full genius potential in an individual.

Utilizing the 24 Characteristics of Genius, identified and quantified by Dr. Alfred Barrios, Genius Inc’s the team at Genius Inc create education to inspire and develop the genius in all.

Rather than rest on his laurels, Bob continues to serve on the boards of organizations and provide hands-on leadership in CEO and other executive roles for specific projects.

Bob oversees a team of top professionals who can execute his vision, offering direct, skillful support and leadership for some of the world’s next great innovations, particularly in the biosciences field.

Current projects include groundbreaking developments in cancer treatment, anti-microbial therapeutics, human longevity and anti-aging technologies, and stem cell research.

Selective. Results-driven. Successful. Dedicated to making a difference for the betterment of all involved. That’s Duggan Investments.

Bob Duggan served on the board of the fledgling pharmaceutical company, Pharmacyclics, in 2008. The company faced imminent bankruptcy. Stock traded at values from as little as $3 each to less than a dollar apiece. The CEO quit. It looked like a sinking ship.

Bob didn’t just stay on at Pharmacyclics. He doubled down. He took the helm and invested heavily, becoming Pharmacyclics’ largest shareholder.

Finally, the breakthrough: a B-cell cancer drug (IMBRUVICA®) highly effective for treating chronic lymphocytic leukemia (CLL), the most common form of adult leukemia.

In what became known as one of the greatest trades Wall Street has ever seen, Bob negotiated the sale of Pharmacyclics in 2015 to AbbVie, for $261.25 per share–a sum totaling $21 billion.

Where the talents of surgeons and technology merge comes robotic-assisted surgery (RAS).

Like several of Bob’s other investment projects, Intuitive Surgical seeks to make a lasting improvement in the biosciences field.

When computers operate, equipped with the right software and guided by the right surgical hands, patients benefit. Less-invasive procedures occur, with smaller incisions and enhanced precision. These surgeries then result in improved outcomes and recovery, less trauma, and minimized scarring for patients.

Intuitive Surgical’s current offerings, the da Vinci™ and ZEUS® surgical system platforms provide precision and innovation, along with real-time 3D monitoring, to surgeons and hospitals, for various surgical procedures each year.

In the mid-1990s, Bob and his son, Demian Duggan, would begin a project to help former communist countries transition to capitalism, Metropolis Media.

Serving as the chairman of the board and personally investing 100% of the $3 million initial financial capital, Bob would oversee this organization’s spread to outdoor media projects in an estimated 10,000 locations throughout Eastern Europe, in Croatia, Slovenia, Serbia, Bosnia and Macedonia.

Eventually, Capital Research purchased this family-run enterprise at a price of over $45 million– 15 times greater than Bob’s initial investment. Metropolis Media is now owned by French advertising giant JCDecaux Group.

When Bob Duggan helmed Communication Machinery Corp (CMC), they were only the third company in the world to create and sell Ethernet Node-Processors, the computer networking technology utilized for establishing local area networks (LAN) and providing a gateway to the internet.

Another technology developed at CMC used bit-slice-based intelligence to function as both a front-end processor and a key-to-disk computer terminal in one seamless system. These workstations allowed companies and governments better data capture than many other technologies available at the time.

After successful growth and marketing, under Bob’s leadership, CMC held an 80% market share in this specific type of computer workstation, enabling a sale to Rockwell International for $45 million.

In the 1980s, Bob Duggan founded Government Technology Services, Inc (GTSI) to assist, mostly government agencies, to acquire new, much-needed computer technologies.

GTSI engaged in some notable firsts: the first browser-based government contract catalog, the first-ever use of a credit card on the internet (as part of a deal with NASA), and the first government IT portal. Combined, these firsts positioned GTSI as an early pioneer in the new field that would become e-commerce.

Under Bob’s leadership, GTSI grew from an $8 million company to over $600 million in revenue, ultimately acquired by UNICOM Global (where it still operates under UNICOM Government, Inc).

A bakery might seem like an unlikely origin for a man who would go on to helm technology and pharmaceutical companies, but who doesn’t love a good cookie?

One of Bob’s earliest projects was Paradise Bakery in Long Beach, California. In those early days, Bob played a very hands-on role in the day-to-day operations of the bakery business, even inventing a chocolate chip cookie recipe, the “Chocolate Chip Chipper.”

Paradise pioneered premium baked goods distribution, partnering with such companies as McDonald’s, Kentucky Fried Chicken and Disney World. They grew to over 70 locations in 10 states, ultimately selling to Panera Bread company.

You can still enjoy an independent Paradise Bakery if you visit the Aspen, Colorado store still owned by Duggan’s business partners, Carter Holmes and brothers Danny and Mark Patterson. They’re scouting a new location, but chocolate chip cookies are always on the menu and available by the dozen.

An early investment project of Bob’s involved the relatively modest sum of $100,000. In 1975 he invested in Jiffy Stitchery, a children’s embroidery set company, with money that amounted to 50% of the company’s venture capital, in exchange for 50% equity and a seat on the board.

From his board position, Bob guided the marketing and financial decisions of the burgeoning company. Soon, more than 7,000 retail stores sold Jiffy Stitchery sets, with Sunset Designs holding over 80% of the market share with their simple, colorful and aesthetic designs.

The company sold in the mid-1980s to British multinational consumer goods company, Reckitt Benckiser Group, with a return rate of more than 150 times Bob’s initial investment.